Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 5, keine Gesamtzahl für „Abilify“
Suchtreffer
Begriffe & Kennungen
Abilify Maintena · 4.8 · The incidences of the ADRs associated with aripiprazole therapy are tabulated below. The table is based on adv
Eintrag öffnenAbilify Maintena · 4.8 · The most frequently observed ADRs reported in ≥ 5 % of patients in two double-blind, long-term trial of Abilif
Eintrag öffnenAbilify Maintena · 4.8 · The most frequently observed adverse drug reactions (ADRs) reported in ≥ 5 % of patients in two double-blind,
Eintrag öffnenAbilify Maintena · 4.8 · The safety profile of Abilify Maintena 960 mg and Abilify Maintena 720 mg for the treatment of schizophrenia i
Eintrag öffnenAbilify Maintena · 4.8 · Weight During the double-blind, active-controlled phase of the 38-week long-term trial (see section 5.1), the
Eintrag öffnenAbilify Maintena · 4.8 · Weight During the double-blind, active-controlled phase of the 38-week long-term trial (see section 5.1), the
Eintrag öffnenAbilify Maintena · 4.8 · a: Reported as very common in Abilify Maintena 960 mg/720 mg clinical trials. b: Reported only in Abilify Main
Eintrag öffnenAbilify · 4.1 Therapeutic indications · 1
Eintrag öffnenAbilify · 4.1 Therapeutic indications · 2
Eintrag öffnenAbilify · 4.1 Therapeutic indications · 3
Eintrag öffnenAbilify · 4.1 Therapeutic indications · 4
Eintrag öffnenAbilify · 4.3 Contraindications · 1
Eintrag öffnenAbilify · 4.3 Contraindications · 2
Eintrag öffnenAbilify · 4.3 Contraindications · 3
Eintrag öffnenAbilify · 4.3 Contraindications · 4
Eintrag öffnenAbilify · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAbilify · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAbilify · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAbilify · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAbilify · 4.4 Special warnings and precautions for use · 1
Eintrag öffnen